Drug recall · June 17, 2020
Unasyn (ampicillin sodium/sulbacatam) for injection recall
Why: Presence of Particulate Matter: particulate matter identified after reconstitution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy Distributed by Roerig Division of Pfizer Inc. New York, NY 10017 vial NDC 0049-0013-81, carton NDC 0049-0013-83
- Lots / codes
Lot # 3301612, EXP 02/2022
- Quantity
- 94320 units
- Company
- Pfizer Inc., New York, NY
- Distribution
- Distributed Nationwide in the US
- Initiated
- May 29, 2020 · Voluntary: Firm initiated
- Classified
- June 12, 2020
- Reported
- June 17, 2020
- Ended
- January 13, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ampicillin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.